Ubs Group Ag Concert Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$4.34 - $5.84 $28,470 - $38,310
-6,560 Reduced 47.33%
7,301 $42,000
Q3 2022

Nov 10, 2022
BUY
$4.27 - $7.2 $17,686 - $29,822
4,142 Added 42.62%
13,861 $94,000
Q2 2022

Aug 10, 2022
SELL
$2.8 - $6.36 $17,771 - $40,366
-6,347 Reduced 39.51%
9,719 $41,000
Q1 2022

May 16, 2022
SELL
$2.73 - $3.94 $6,505 - $9,389
-2,383 Reduced 12.92%
16,066 $54,000
Q4 2021

Feb 14, 2022
SELL
$2.69 - $4.22 $27,481 - $43,111
-10,216 Reduced 35.64%
18,449 $58,000
Q3 2021

Nov 15, 2021
BUY
$3.17 - $4.15 $9,893 - $12,952
3,121 Added 12.22%
28,665 $94,000
Q2 2021

Aug 13, 2021
SELL
$3.77 - $5.24 $45,168 - $62,780
-11,981 Reduced 31.93%
25,544 $108,000
Q1 2021

May 12, 2021
BUY
$4.86 - $13.07 $3,800 - $10,220
782 Added 2.13%
37,525 $188,000
Q4 2020

Feb 11, 2021
BUY
$9.48 - $12.84 $23,880 - $32,343
2,519 Added 7.36%
36,743 $465,000
Q3 2020

Nov 12, 2020
SELL
$8.67 - $10.82 $150,268 - $187,532
-17,332 Reduced 33.62%
34,224 $336,000
Q2 2020

Jul 31, 2020
SELL
$7.8 - $11.52 $57,696 - $85,213
-7,397 Reduced 12.55%
51,556 $513,000
Q1 2020

May 01, 2020
SELL
$5.98 - $13.09 $117,662 - $257,558
-19,676 Reduced 25.02%
58,953 $521,000
Q4 2019

Feb 14, 2020
SELL
$5.71 - $9.22 $18,723 - $30,232
-3,279 Reduced 4.0%
78,629 $726,000
Q3 2019

Nov 14, 2019
BUY
$5.88 - $12.35 $82,813 - $173,937
14,084 Added 20.77%
81,908 $482,000
Q2 2019

Aug 14, 2019
BUY
$9.44 - $13.12 $53,269 - $74,036
5,643 Added 9.08%
67,824 $814,000
Q1 2019

May 14, 2019
BUY
$12.07 - $17.54 $27,097 - $39,377
2,245 Added 3.75%
62,181 $751,000
Q4 2018

Feb 14, 2019
SELL
$11.25 - $16.17 $191,700 - $275,536
-17,040 Reduced 22.14%
59,936 $752,000
Q3 2018

Nov 14, 2018
SELL
$12.82 - $17.88 $2,717 - $3,790
-212 Reduced 0.27%
76,976 $1.14 Million
Q2 2018

Aug 14, 2018
SELL
$16.83 - $21.66 $818,947 - $1.05 Million
-48,660 Reduced 38.67%
77,188 $1.3 Million
Q1 2018

May 15, 2018
SELL
$19.24 - $28.03 $3.21 Million - $4.68 Million
-167,006 Reduced 57.03%
125,848 $2.88 Million
Q4 2017

Feb 14, 2018
BUY
$13.96 - $29.05 $480,503 - $999,901
34,420 Added 13.32%
292,854 $7.58 Million
Q3 2017

Nov 14, 2017
BUY
$13.91 - $15.31 $2.23 Million - $2.46 Million
160,449 Added 163.75%
258,434 $3.81 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-16,081 Reduced 14.1%
97,985 $1.37 Million
Q1 2017

Nov 14, 2017
BUY
N/A
114,066
114,066 $1.95 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email